After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Abstract: A/D converter and digital signal as an analog signal interface circuit, the data processing has a very important role, A/D converter and microcontroller interface design directly affects the ...

You may have noticed an officer standing just behind the President of India at official events, state visits, or ceremonial functions. That officer holds a very important role as an Aide-de-Camp (ADC) ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Emrelis marks a pivotal moment for ADC therapies in oncology, reflecting the FDA’s growing confidence in ...

Nigeria's two main opposition leaders have joined a new political party to challenge President BolaTinubu and his ruling party in the next election. Atiku Abubakar and Peter Obi have chosen the ...

ABUJA – In a bold move to reposition itself as a credible opposition platform, the African Democratic Congress (ADC) has approved the appointment of several prominent political figures, including ...

The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to refine ...

Lieutenant Commander Yashasvi Solanki, 27, has been appointed as the first female Aide-de-Camp (ADC) to the President of India, Droupadi Murmu. This appointment has marked a significant milestone for ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for development of this antibody-drug conjugate. EBC-129, a novel ADC for the ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...